Navigation Links
Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
Date:10/8/2007

Jim Slevin Joins from CV Therapeutics as Senior Director of Account

Management, Integrated Healthcare Management

PARSIPPANY, N.J., Oct. 8 /PRNewswire/ -- Valeritas, LLC, a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has hired Jim Slevin to serve as the Senior Director of Account Management, Integrated Healthcare Management.

Mr. Slevin will join the Integrated Healthcare Management team reporting directly to Matt Nguyen, PharmD. Jim will be responsible for reimbursement strategies, marketing programs and contract development with national, regional, and government payers for Valeritas products in the metabolism arena. In the near term, he will focus on the h-Patch(TM) -- a once-daily, disposable insulin delivery device that is scheduled for a regional launch in Q1 2008.

"Jim comes to Valeritas with more than 20 years of experience in account management, during which he developed vast relationships and earned significant respect from his customers," said Robert Gonnelli, President and CEO of Valeritas. "Jim has been part of managed care since its infancy, has seen it grow and evolve, and knows the importance of success in this arena. His stellar track record in previous launches to ensure access and more importantly, preferred status, will no doubt contribute to the overall success of the h-Patch(TM) launch."

"Being part of the h-Patch(TM) launch is truly exciting," said Mr. Slevin. "The burden of diabetes in the U.S. from a payor's perspective is significant. The h-Patch(TM) is a first-in-class technology with a significant opportunity to improve patient care. With its ease of use and potential to improve patient compliance and control, h-Patch(TM) utilization can help reduce overall healthcare costs for patients with diabetes. I look forward to working with my customers to share the cost-benefits associated with the h-Pat
'/>"/>

SOURCE Valeritas, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Merge Healthcare hires new VP of finance
3. PDS hires new VP, buys former health club building
4. SecurePipe appoints two senior execs
5. Third Wave announces two senior management appointments
6. Senior Wisconsin stem-cell researcher leaves for Connecticut
7. Sonic Foundry names new senior vice president
8. Fiserv enters health-care savings accounts business
9. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
10. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
11. Why IT change management is more important than ever
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  BioClinica®, Inc., a leading specialty ... announced that clinical trial professionals representing 20 ... annual European User Conference in ... use of its eClinical technologies to overcome ... the Microsoft Office-Smart OnPoint CTMS; Express EDC; ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Reaction (PCR) represents one of the fastest growing technologies ... cell biologists in subcellular visualization is driving growth in ... need for deeper understanding of gene expressions will continue ... market. Expanding applications in fields ranging from pharma, biotech, ...
(Date:3/4/2015)... -- Lancée par l,Assistance Publique ... en décembre 2011, l,étude collaborative française randomisée et ...   l es microsphères en résine marquées ... carcinome hépatocellulaire avancé, a recruté plus de 400 ... ; les résultats sont attendus fin 2016.   ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... effort to spur growth in the community and provide ... city of Whitewater and the Wisconsin ... business incubator, according to a report in the Wisconsin ... a $10,000 state grant to determine the characteristics of ...
... Wis. - Johnson Controls , responding to ... the launch of a new business division to develop ... new renewable technologies unit will focus on geothermal, solar, ... , ,Johnson Controls expects increased demand for these ...
... about being disappointed by not being able to visit a ... view of their services after an executive scheduled a meeting with ... I would get. Several calls came in within 15 minutes of ... a lot to say about watching claims made within the data ...
Cached Biology Technology:Data centers: Buyers beware of over-hyped facilities 2Data centers: Buyers beware of over-hyped facilities 3Data centers: Buyers beware of over-hyped facilities 4
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... at Lawson Health Research Institute and Western University have ... adenovirus, causes disease. In doing so, they have discovered ... responses. Their findings, published today in Cell Host ... and cancer. Adenovirus infections most often cause mild ...
... MASS. The landmark publication this week of a "map" ... in an unexpected place: the ocean. Microbial communities that ... the microbiome, are thought to have a critical role in ... of Health launched the ambitious Human Microbiome Project (HMP) to ...
... using overlooked employee talent has taken a top award ... an associate professor in NJIT School of Management, is ... from Positive Deviance." Curt Lindberg, of Complexity Partners, ... the 2012 Best Paper Award from the Organization Development ...
Cached Biology News:London researchers discover novel mechanism involved in key immune response 2More than 1 way to be healthy: Map of bacterial makeup of humans reveals microbial rare biosphere 2More than 1 way to be healthy: Map of bacterial makeup of humans reveals microbial rare biosphere 3How alert hospital employees improved hospital's MSRA infection rate 2How alert hospital employees improved hospital's MSRA infection rate 3
... standard fixed-angle microcentrifuge rotor at RCF ... tube filters consist of a membrane-containing ... They filter by centrifugation for bacteria ... removal of cells from media and ...
... binding) polystyrene surface is hydrophobic in ... interactions,• Is suitable primarily for the ... antibodies, that have large hydrophobic regions ... Binding capacity of approximately 250 ng ...
... module C, 0.7 mm depth • Reusable, ... can be quickly assembled and disassembled for ... specimens of any thickness with up to ... three chambers per slide. Minimize specimen handling, ...
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
Biology Products: